|Chemical and physical data|
|Molar mass||329.232 g·mol−1|
|3D model (JSmol)|
SSR180711 is a drug that acts as a potent and selective partial agonist for the α7 subtype of neural nicotinic acetylcholine receptors. In animal studies, it shows nootropic effects and may be useful in the treatment of schizophrenia.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|